Condensed Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data |
3 Months Ended | 9 Months Ended | 121 Months Ended | ||
---|---|---|---|---|---|
Sep. 30, 2011 |
Sep. 30, 2010 |
Sep. 30, 2011 |
Sep. 30, 2010 |
Sep. 30, 2011 |
|
Condensed Consolidated Statements Of Operations [Abstract] | |||||
Revenue | $ 5,027 | ||||
Operating expenses: | |||||
Research and development | 6,481 | 4,773 | 17,646 | 14,194 | 196,293 |
General and administrative | 1,308 | 1,297 | 4,290 | 3,591 | 67,787 |
Total operating expenses | 7,789 | 6,070 | 21,936 | 17,785 | 264,080 |
Loss from operations | (7,789) | (6,070) | (21,936) | (17,785) | (259,053) |
Interest income (expense), net | 5 | 14 | 20 | 53 | 8,339 |
Other income (expense) | 3,659 | 148 | 1,538 | 5,604 | 4,393 |
Net loss | (4,125) | (5,908) | (20,378) | (12,128) | (246,321) |
Dividend related to beneficial conversion feature of redeemable convertible preferred stock | (40,862) | ||||
Net loss attributable to common stockholders | $ (4,125) | $ (5,908) | $ (20,378) | $ (12,128) | $ (287,183) |
Net loss per common share, basic and diluted | $ (0.08) | $ (0.18) | $ (0.45) | $ (0.36) | |
Weighted average number of shares used in per common share calculations: basic and diluted | 49,052 | 33,672 | 44,812 | 33,638 |
X | ||||||||||
- Definition Dividend related to beneficial conversion feature of redeemable convertible preferred stock.
|
X | ||||||||||
- Definition Noncash expense related to change in warrant valuation.
|
X | ||||||||||
- Definition Weighted Average Number Of Shares Outstanding Basic And Diluted1
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues.
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|